Garofalo Elizabeth A.

Garofalo Elizabeth A. is listed in filings as Director at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE), ACADIA Pharmaceuticals Inc. (ACAD), and Alector, Inc. (ALEC). The current snapshot covers public activity from Jun 12, 2024 to Jun 3, 2026. Reported amounts are shown as $561.7K to $41.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.